ESMO-话题@MedSci

#ESMO#

215篇内容 | 7532人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1280886, encodeId=dce11280886e8, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）, objectType=article, longId=27180, objectId=0e472e180a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e472e180a3, replyNumber=0, likeNumber=137, createdTime=2013-11-29, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e472e180a3, moduleTitle=ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e472e180a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280885, encodeId=8208128088566, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2013：FIRE-3研究新数据解读, objectType=article, longId=26761, objectId=d7d526e61d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d526e61d5, replyNumber=0, likeNumber=0, createdTime=2013-11-21, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d526e61d5, moduleTitle=ESMO 2013：FIRE-3研究新数据解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d526e61d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280884, encodeId=67271280884ad, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO年会：来那度胺治疗晚期前列腺癌生存率低, objectType=article, longId=10379, objectId=3aef103e954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aef103e954, replyNumber=0, likeNumber=109, createdTime=2012-10-14, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aef103e954, moduleTitle=ESMO年会：来那度胺治疗晚期前列腺癌生存率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aef103e954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280883, encodeId=7e08128088317, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO年会：抗肾细胞癌疫苗研究取得进展, objectType=article, longId=10100, objectId=570a1010092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=570a1010092, replyNumber=0, likeNumber=96, createdTime=2012-10-10, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=570a1010092, moduleTitle=ESMO年会：抗肾细胞癌疫苗研究取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=570a1010092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2012 ESMO临床实践指南：结直肠癌, objectType=article, longId=10047, objectId=eb151004e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb151004e9e, replyNumber=0, likeNumber=121, createdTime=2012-10-04, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb151004e9e, moduleTitle=2012 ESMO临床实践指南：结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb151004e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280881, encodeId=d06b1280881a0, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=第35届欧洲肿瘤内科学会（ESMO）大会纪要, objectType=article, longId=2249, objectId=029c2249e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=029c2249e5, replyNumber=0, likeNumber=104, createdTime=2010-11-28, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=029c2249e5, moduleTitle=第35届欧洲肿瘤内科学会（ESMO）大会纪要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=029c2249e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280880, encodeId=2bbd128088095, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO：一些重要癌症研究报告将陆续公布, objectType=article, longId=2192, objectId=35032192c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35032192c2, replyNumber=0, likeNumber=124, createdTime=2010-10-15, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35032192c2, moduleTitle=ESMO：一些重要癌症研究报告将陆续公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35032192c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ESMO

2020-05-29

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）

2013-11-29

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2013：FIRE-3研究新数据解读

2013-11-21

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO年会：来那度胺治疗晚期前列腺癌生存率低

2012-10-14

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO年会：抗肾细胞癌疫苗研究取得进展

2012-10-10

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2012 ESMO临床实践指南：结直肠癌

2012-10-04

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

第35届欧洲肿瘤内科学会（ESMO）大会纪要

2010-11-28

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO：一些重要癌症研究报告将陆续公布

2010-10-15

科室
- - 订阅+
  - 更多科室
工具
服务